What's New in Research Funding

Molecular structuresPage last updated March 17, 2020

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the C. David Naylor Building, Suite 119, 6 Queen’s Park Cres W. to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact golnaz.farhat@utoronto.ca..
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates

 

March 17, 2020
 

  • EMHSeed Call for Proposals: Expanding research impact through inter-disciplinary collaboration. EXTENDED DEADLINE. The Joint EMHSeed and XSeed is an interdivisional research funding program designed to promote multi-disciplinary research and catalyze new innovative partnerships between a coPI from the Faculty of Applied Science and Engineering (FASE) and a coPI from outside Engineering. Partner divisions for EMHSeed: Faculty of Medicine (FoM), UofT Affiliated Hospitals, Medicine by Design (MbD), Translational Biology and Engineering Program (TBEP). The budget for each Seed project will be $60,000 CAD/year for two (2) years. In exceptional cases, a no-cost extension for an additional year will be considered. The $60,000 CAD/year amount for each project is the sum of total cash invested by each of the participating Faculties and departments/institutes. Deadline for proposals has been EXTENDED to: April 20, 2020.
     

  • NSERC Alliance Grants Workshop – Postponed. In compliance with guidelines restricting non-essential travel due to concerns over containment of COVID-19, NSERC, the Natural Sciences and Engineering Research Council, has postponed the on-campus visit to discuss the new NSERC-Alliance grant program, previously scheduled for April 8, 2020. The visit and workshop will be rescheduled later this year, and an announcement regarding the revised date will be made once such restrictions are lifted. In the meantime, the Innovations & Partnerships Office will continue to collect your questions; these questions will continue to be relayed to NSERC as appropriate for timely answers. Please continue to use “NSERC Alliance Question” as the email title, and send it to Colin Swift, Business Development Officer – Industry Partnerships. For more information about the NSERC Alliance program, please visit here.
     

  • On March 19th MROL moves to My Research Portal. Beginning March 19th, the link to My Research On-Line (MROL) will be removed and all users will access MROL via the My Research portal. This consolidation will streamline access to the system, and is part of the U of T Enterprise Modernization Program. Details on how to access My Research On Line (MROL) can be found here.
     

  • Physician's Services Inc. (PSI) Foundation: COVID-19 Research Stream. PSI Foundation invites all eligible clinician researchers to apply for this special funding stream. PSI will fast-track the processing of COVID-19 applications and aim for full review at our June 2020 Grants Committee meeting. Please submit your applications as soon as possible. 

 

March 11, 2020
 

  • NSERC Alliance Grants Workshop – Confirmed Details. A recent Research Alert reported that NSERC, the Natural Sciences and Engineering Research Council, recently launched its new Alliance grant program, replacing previous Research Partnerships Programs such as Engage, CRD, IRC, and Strategic Partnerships. It announced that NSERC personnel would be presenting a workshop on the St. George campus to provide an update and answer your questions.. NSERC will be on campus to give a workshop providing an in-depth look at Alliance Grants. The session will focus on how to apply to Alliance, the newly opened Option 2 stream, and an overview of application best practices. The workshop will be followed by a question and answer period.
    DATE: Wednesday, April 8, 2020 from 1pm - 3pm
    LOCATION: Bahen Centre (40 St. George St.), Rm 1190

     

  • Tri-Agency (CIHR, NSERC, SSHRC) Update: Travel Cancellation fees due to COVID-19. The three federal granting agencies are aware that the rapidly changing situation involving COVID-19 may have an impact on researchers with plans to travel for meetings or other research-related activities. Individuals may decide to cancel trips as a result of various considerations and factors such as cancelled conferences, travel advisories (including those from Health Canada and Global Affairs Canada), or personal choice due to health or other concerns. The agencies confirm that the reimbursement of non-refundable travel fees from agency funds is acceptable considering the impacts of COVID-19. This applies to the travel of both principal investigators and research personnel, when cancellation occurs as described above. Read more.
     

  • 2020 Provost's Postdoctoral Fellowship Program: Supporting Researchers from Underrepresented Groups. The University of Toronto Provost’s Postdoctoral Fellowship program provides funding to Graduate Faculties to increase opportunities for hiring postdoctoral fellows from underrepresented groups, specifically Indigenous and Black researchers. The funding will enable postdoctoral researchers to grow their scholarly profiles, undertake academic work at the University of Toronto, and strengthen the research environment at the University with diverse perspectives. Each award will provide $70,000 per year to Faculties to support up to two years of postdoctoral salary and benefits. Further details here.
     

  • Ontario Brain Institute ONtrepreneurs Program - $50,000 to Build Your Neurotech Venture. The Ontario Brain Institute's (OBI) ONtrepreneurs Program funds and supports early-stage entrepreneurs pursuing entrepreneurial and/or commercialization opportunities to help establish neuroscience-related companies in the NeuroTech Ontario cluster. OBI is offering up to 10 awards of $50,000 + mentorship + training opportunities for early-stage entrepreneurs to develop and commercialize technologies that impact people, researchers or clinicians involving a brain disorder or brain health. The program provides up to $50,000 over a one-year period to help post-graduate students focus full-time on commercialization activities related to a neuroscience-based opportunity. OBI Entrepreneurs are assigned industry-based mentors and a dedicated point of contact at OBI for professional and personal support throughout the year. The program is open to new or early-stage entrepreneurs based in Ontario. MSc/PhD grads, scientists, engineers, computer scientists and others with entrepreneurial interests. Deadline for applications: April 1, 2020.
     

  • Canadian Cancer Society: Impact Grants. The Impact Grant program supports significant progression in cancer research programs that are anywhere in the continuum from basic, high impact discovery, to translational work of direct relevance to the clinic, to applied research. Impact Grants aim to accelerate and focus the knowledge gained from scientific findings, in the short- to medium-term, into outcomes that will: significantly improve scientific knowledge relevant to cancer; result in improved cancer treatment; result in optimized care of people living with and beyond cancer; and/or result in reduced cancer burden. The goal of the CCS Research Impact Grant program is to provide a mechanism for scientists to accelerate the application of new knowledge and apply innovations to address important problems in cancer research and care. Amount: Up to $300,000 per year and a maximum of $1,500,000 per grant. Grants are renewable. Deadline for Letters of Intent: April 29, 2020.

  • Simons Foundation Autism Research Initiative (SFARI): Pilot Award. The goal of the Pilot Award is to provide early support for exploratory ideas, particularly those with novel hypotheses. Appropriate projects for this mechanism include those considered higher risk but with the potential for transformative results. In particular, they encourage applications that propose research to link genetic or other ASD risk factors to molecular, cellular, circuit or behavioral mechanisms of ASD. Amount: Up to USD $300,000 over two years including 20% in indirect costs. Deadline for applications: April 24, 2020.
     

  • Lung Cancer Research Foundation:

    • Research Grant on Disparities in Lung Cancer. While scientific advances continue to reduce lung cancer incidence and deaths, the disease disproportionately affects various groups such as African Americans, Native Americans, low socioeconomic status populations and people from certain geographic locations. Despite progress to reduce the burden of tobacco, disparities in tobacco-related morbidity and mortality remain, and inequitable receipt of evidence-based lung cancer care continues to compound these disparities. To help address these and related challenges, LCRF will support two research projects in 2020 with a focus on overcoming disparities in lung cancer. Amount: USD $150,000 over two years. Deadline for applications: May 1, 2020.

    •  Pilot Grant Program. The goal of the LCRF pilot grant program is to fund innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, and other research. Amount: USD $150,000 over two years. Deadline for Letters of Intent: May 1, 2020.
       

  • Tuberous Sclerosis Alliance (TS Alliance): Research Grants Program. Most TS Alliance research grants support small, focused projects that allow investigators to develop preliminary data to compete for funding from larger organizations such as the National Institutes of Health (NIH). Other TS Alliance research grants support post-doctoral fellowships to encourage young investigators to engage in TSC research. Many of these investigators will continue to pursue TSC research when they establish their own independent laboratories. The TS Alliance offers Postdoctoral Fellowships and Research Grants. Amount: USD $150,000 over two years. Deadline for Letters of Intent: April 6, 2020.
     

  • The Michael J. Fox Foundation for Parkinson's Research (MJJF): Attend their informational webinar on March 27, 2020, at 12 p.m. ET to learn more about our Foundation's funding strategy and opportunities, and the application and review processes. Register here.

    • Therapeutic Pipeline Program. Proposals should focus on strategies with clear impact for people with Parkinson's and well-defined development plans. Programs developing novel approaches as well as approved or clinically safe repurposed or repositioned therapies from other disease indications are appropriate for this RFA. MJFF will prioritize clinical and pre-clinical approaches built on strong scientific and biological rationale for targeting fundamental processes underlying Parkinson's cause, progression and/or non-motor and motor symptom expression. Amounts: Up to USD $500,000 for Pre-Clinical Program; Up to USD $2,000,000 for Clinical Program. Deadline for preliminary proposals: April 23, 2020.

    • Parkinson's Pathway Biomarkers. Ultimately, their goal is to develop better biomarkers for PD diagnosis, disease progression, patient stratification, and/or pharmacodynamic readouts for clinical trials. Currently, many efforts are focusing on understanding the role of various cellular processes/pathways in PD and uncovering novel targets within these pathways for therapeutic development. Amount: Up to USD $300,000 for up to two years. Deadline for preliminary proposals: April 23, 2020.

    • Target Advancement Program.  Funding will support projects focused on validating targets and defining pathways implicated in PD pathological processes and/or symptomology. Amount: Up to USD $200,000 for up to 18 months. Deadline for preliminary proposals: April 23, 2020.

    • Investigating Environmental Factors that increase the Risk for Parkinson's Disease.  This program supports the analysis of large epidemiological datasets to identify environmental risk factors, such as exposure to chemicals, toxic emissions, air pollutants, and dietary contaminants, which are associated with an increased risk of PD. MJFF is especially interested in funding projects that utilize large longitudinal datasets and will prioritize collaborative efforts that bring together teams of investigators with access to multiple diverse datasets. Amount: Up to USD $400,000 for up to two years. Deadline for preliminary proposals: April 23, 2020.
       

  • Worldwide Cancer Research: Research Grants.  Worldwide Cancer Research provides funding for basic, fundamental or translational research into the prevention, diagnosis or treatment of cancer. Applications on cancer symptoms or treatment side effects are accepted only if there is a very clear link to improving cancer survival. Studies investigating the biology of a side effect or symptom alone are unlikely to be accepted. Basic studies into fundamental cellular processes, mechanisms and molecules are within remit if it is clear that the aim of the research is to improve the understanding of cancer biology. Amount Up to GBP £250,000 for up to three years. Deadline for applications: April 3, 2020.
     

  • Society for Pediatric Dermatology: Childhood Eczema Challenge Grant. This Challenge Grant is intended to stimulate early and mid-career scientists as they seek to build and sustain careers as research investigators and future thought leaders within this critical field of study. Research proposals should address at least one of the following priorities related to pediatric eczema: Eczema Heterogeneity: Novel Insights; Innovations in Clinical Practice & Care; Understanding & Alleviating Disease Burden; and Eczema Prevention. Amount: Up to USD $50,000 for one year. Deadline for applications: May 1, 2020.
     

  • American Academy of Pediatrics (AAP): Research Grant and Young Investigator Award Program. What are the best ways to optimize care in the delivery room using Neonatal Resuscitation Program (NRP)? Initiatives can include teaching and evaluating the cognitive, technical and behavioral skills necessary for successful resuscitation of the newborn and retention of skills and knowledge over time.
    - NRP Human Factors or Education Grant (up to USD $15,000)
    - NRP Young Investigator Award (up to USD $15,000)
    - NRP Research Grant Program (up to USD $50,000)
    Deadline for Notices of Intent: April 10, 2020.

 

March 5, 2020
 

  • NSERC Alliance Grants Workshop - Your Questions Answered. NSERC recently launched its new Alliance grant program, replacing previous Research Partnerships Programs such as Engage, CRD, IRC, and Strategic Partnerships. The Innovations & Partnerships Office (IPO) is setting up a workshop with NSERC personnel, to discuss progress so far on Option 1, as well as the Option 2 launch. NSERC personnel will be present on campus to address your specific concerns and comments at this workshop in early April – exact date and time still to be determined. To maximize usefulness of this workshop, all interested PI applicants are invited to provide their questions in advance to IPO. These questions will be collected, curated/anonymized, and forwarded to NSERC to ensure they are addressed at the April workshop. Questions for NSERC can be emailed to IPO c/o Colin Swift, Business Development Officer – Industry Partnerships – for clarity, please use NSERC Alliance Question as the email title. Please provide these questions to IPO by Friday, March 20, 5pm EDT. Further specific information on the April workshop will be communicated via a subsequent Research Alert. Visit here for more information about the NSERC Alliance program.
     

  • Commercialization Grants – NSERC Idea to Innovation (I2I). Four times per year, NSERC accepts applications for its “Idea to Innovation” (I2I) program, for the purpose of accelerating pre-competitive technologies for transfer to a Canadian company. Successful applicants receive awards of up to $125,000 for each phase of their commercialization project, with additional funding available as the project progresses. All projects must be based on inventions disclosed and assigned to the University, and should be managed in conjunction with the Innovations & Partnerships Office (IPO) – the Innovations team in particular can assist with development of the Commercialization Plan, and can also assist in determining the appropriate Phase for your project. For more information please contact IPO's intake email innovations.partnerships@utoronto.ca or visit NSERC's website. UofT internal deadline: March 20, 2020; Sponsor deadline: March 30, 2020.
     

  • 2020 Medicine by Design: Post-Doctoral Fellowship Awards. This award will provide funding to high calibre post-doctoral candidates at the University of Toronto and its affiliated hospitals who demonstrate outstanding potential to become independent researchers in the regenerative medicine field. Each award provides up to $75,000 per year in salary support for two years, from May 1, 2020 to April 30, 2022. Funds cannot be used for travel or other expenditures.  Proposed projects must align with at least one of the Medicine by Design priority areas: 1) developing cell therapies to cure disease; 2) finding new approaches to promote endogenous repair and regeneration; 3) accelerating the path from basic research to clinical application; 4) addressing long-standing fundamental questions in regenerative medicine; or 5) minimizing tissue dysregulation or degeneration. Special consideration will be given to applications that use an engineering design approach integrating quantitative tools (e.g. mathematical modelling, single cell analytics) and control methods (e.g. synthetic biology) to address the above priority areas. Deadline for applications: March 25, 2020 at 5pm EST.
     

  • Canadian Cancer Society (CCS): Research Grants for Uterine Carcinosarcoma and Other Aggressive Uterine Cancers. The CCS is issuing a special call for grant applications focused on rare and aggressive uterine cancers, with an emphasis on uterine carcinosarcoma in particular. As a result of a generous donation, there is funding available to support one meritorious application that will impact our understanding of uterine carcinosarcoma and other aggressive uterine cancers, particularly as it relates to the prevention, early detection, diagnosis, and/or treatment of these hard-to-treat cancers. The funding envelope will support a budget of up to $180,000 over 2 years (maximum of $90,000 per year). This grant is renewable for an additional 2 years of funding pending review. Deadline for applications: April 6, 2020.
     

  • Lupus Research Alliance: Distinguished Innovator Awards in Lupus. This grant mechanism is intended to attract exceptionally creative scientists from all relevant scientific disciplines and to provide them with robust and sustained support to explore bold and paradigm shifting ideas that could lead to ground-breaking discoveries in lupus research. Investigators working in areas outside of lupus are strongly encouraged to apply. The Distinguished Innovator Awards provide outstanding scientists with substantial support to conduct novel research into the fundamental causes of systemic lupus erythematosus and so provide new directions towards a cure. Amount: Up to USD $250,000 per year for up to four years. Deadline for Letters of Intent: March 16, 2020; Full application deadline: June 30, 2020.
     

  • Alzheimer's Association.
    - Alzheimer's Association Research Grants (AARG): The purpose of this program is to provide newly independent investigators with funding that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses. The intent is to support early-career development that will lay the groundwork for future research grant applications to federal or other funding entities, like the National Institutes of Health, including future proposals to the Alzheimer's Association. Amount for total award: Up to USD $150,000 for up to 3 years. Deadline for Letters of Intent: March 19, 2020; Full application deadline: May 6, 2020.
    Alzheimer's Association Research Grant - New to the Field (AARG-NTF): The purpose of this program is to provide independent investigators with unique expertise and apply their knowledge to Alzheimer's and all dementias. This program aims to provide these investigators with funding to establish a research path in Alzheimer's and all dementias, to develop preliminary or pilot data, to test procedures and to develop hypotheses. Individuals who are new to the field of neuroscience or neurodegeneration (Alzheimer's, Parkinson's, Lewy body dementia, etc.) will be considered for this program.  Amount for total award: Up to USD $150,000 for up to 3 years.  Deadline for Letters of Intent: March 19, 2020; Full application deadline: May 6, 2020.
     

  • Huntington's Disease of America: HD Human Biology Project.  The Human Biology Project was launched in 2013 with the goal of fostering innovative research in collaboration with HD clinics to better understand the biology of Huntington's disease as it occurs in humans. HDSA encourages researchers to consider one of HDSA's 50 Centers of Excellence as a potential collaborator, but applicants may propose to work with any HD clinic around the world. 1-2 years of funding to support a scientist working collaboratively with an HD clinic anywhere in the world. Amount: Up to USD $75,000/year ($50,000 salary support and $25,000 research budget). Deadline for Letters of Intent: May 22, 2020; Full application deadline: July 24, 2020.
     

  • Bill & Melinda Gates Foundation: Grand Challenges: Accelerating Discovery for Non-Hormonal Contraceptives. The focus of this Grand Challenge is on broadly enhancing the research ecosystem for contraceptive discovery and advancing novel and bold ideas that can accelerate drug discovery in this field. We do not expect that novel contraceptive product candidates ready for entry into preclinical development will be identified in this early stage of funding. We anticipate, however, that projects funded through this Grand Challenge will identify new drug discovery approaches and technologies that have yet to be effectively applied to contraceptive R&D. Amount: Up to USD $2 million and for up to 3 years, based on the scope of the proposed project. The proposed budget must realistically reflect the technical work and project deliverables within a 3-year timeframe; in some cases, a smaller budget may be justified to establish initial proof-of-concept. Deadline for applications: April 22, 2020. 
     

  • Bill & Melinda Gates Foundation: Grand Challenges Explorations: Innovations for Improving the Impact of Health Campaigns (Round 25). They are seeking innovative solutions that accelerate the improvement of coverage, reach, efficiency, and effectiveness of mass health campaigns that deliver health products or services in low-and middle-income countries, specifically through improved planning/microplanning and focus on unreached populations. Specifically, they are looking for innovations in approaches, practices, or tools that dramatically improve the planning/microplanning that will lead to improved effectiveness of campaigns. They are also looking for innovative tools and technologies to more effectively identify and reach the most vulnerable populations when countries are designing and implementing mass campaigns. Amount: Up to USD $100,000 are made in Phase I. Phase I awardees may have one opportunity to apply for a follow-on Phase II award of up to USD $1,000,000. Deadline for applications: April 22, 2020.
     

  • Pfizer Inc.; Pfizer Global Medical Grants: Gene & Anti-TFPI Therapies in Hemophilia. Projects that will be considered for Pfizer support will focus on the following areas: 1. Basic Science of Gene Therapy for Hemophilia; 2. Basic Science of TFPI & Anti-TFPI Monoclonal Antibodies; 3. Burden of disease: Clinical Hemophilia A and B. Amount: Up to USD $125,000/year for 1 to 2-year projects will be considered. Pfizer anticipates awarding up to 2 grants. Deadline for applications: June 15, 2020.

 

February 25, 2020
 

  • EMHSeed Call for Proposals: Expanding research impact through inter-disciplinary collaboration. The Joint EMHSeed and XSeed is an interdivisional research funding program designed to promote multi-disciplinary research and catalyze new innovative partnerships between a coPI from the Faculty of Applied Science and Engineering (FASE) and a coPI from outside Engineering. Partner divisions for EMHSeed: Faculty of Medicine (FoM), UofT Affiliated Hospitals, Medicine by Design (MbD), Translational Biology and Engineering Program (TBEP). The budget for each Seed project will be $60,000 CAD/year for two (2) years. In exceptional cases, a no-cost extension for an additional year will be considered. The $60,000 CAD/year amount for each project is the sum of total cash invested by each of the participating Faculties and departments/institutes. Deadline for proposals: March 20, 2020.
     

  • 2020 Medicine by Design New Ideas Awards. The 2020 Medicine by Design New Ideas Awards will focus on seeding new ideas that have strong potential to advance regenerative medicine research. Each funded project will receive up to $100,000 per year for a two-year period from July 1, 2020 to June 30, 2022. Proposed projects must align with at least one of the Medicine by Design priority areas: 1) developing cell therapies to cure disease; 2) finding new approaches to promote endogenous repair and regeneration; 3) accelerating the path from basic research to clinical application; 4) addressing long-standing fundamental questions in regenerative medicine; or 5) minimizing tissue dysregulation or degeneration. The EOI template can be accessed online. Please submit by email to stephanie.hume@utoronto.ca by March 20, 2020 at 5 p.m. EST.
     

  • NSERC - Alliance Grants Option 2. NSERC is pleased to announce that Option 2 of Alliance grants is now open and accepting applications. During this initial phase, applications requesting over $30,000 and up to $100,000 per year will be accepted, and the number of applications each applicant (as principal investigator or as co-applicant) may submit will be limited to one within a 12-month period. As with the staged Option 1 introduction in 2019, the full range of Option 2 applications will be accepted only at some point in future. Alliance Option 2 applications will be evaluated in two stages. Complete applications will be submitted to a multidisciplinary and multisectoral selection committee that will assess whether the higher NSERC contribution (associated with Option 2) is justified. The selection committee will meet on a quarterly basis, starting in the Spring of 2020. If selected, applications will then proceed to the second step for review of overall merit, similar to Option 1. NSERC personnel have been invited to present a workshop on optimizing Alliance applications on the downtown St. George campus in late March 2020. Details of this visit will be shared in a subsequent Research Alert.
     

  • NFRF 2020 Horizon Global Platform – Upcoming Bilingual Webinar. On January 31, the New Frontiers in Research Fund (NFRF) launched the 2020 Horizon Global Platform competition that will provide NFRF funds to Canadian researchers who are partners on eligible successful European Union Horizon 2020 calls. Horizon 2020 is the EU’s suite of research and innovation funding programs under which Canadian researchers can join EU teams, but normally not receive EU funding. The NFRF 2020 Horizon Global Platform thus provides the possibility of funding to Canadian researchers if the Horizon 2020 submission is successful. Tri-Agency Institutional Programs Secretariat (TIPS) will be hosting a bilingual webinar followed by a Q&A session for applicants and research administrators about the this competition and the details are below:
    Thursday February 27, 2020
    11:00a.m. -1:00p.m.  EST

    Meeting Link - Password: 929HQfD7mqQ
    The webinar will be recorded and the presentation slides along with the recording will be added to the UofT Funding Opportunity once available.
     

  • Hold’em for Life Oncology Fellowships. Hold’em for Life Charity Challenge has made a generous and transformative commitment to oncology research and education at the University of Toronto’s Faculty of Medicine and our partner hospitals. The Hold’em for Life Oncology Fellowships are open to University of Toronto residents and clinical fellows pursuing cancer research, at any of the Faculty’s nine fully affiliated teaching hospitals. Award Amount: $50,000. Applications will be considered for funding for the following time periods: July 1, 2020 – June 30, 2021    or    July 1, 2021 – June 30, 2022. Visit here to see the eligibility criteria. Application deadline: April 14, 2020.
     

  • Cystic Fibrosis Foundation (CFF).

    • Clinical Research Awards. The intent of the Clinical Research Award program is to provide support for investigator-initiated clinical research projects that have the potential to make an important contribution to the Cystic Fibrosis Foundation's mission. Research projects may address diagnosis, treatment, management of disease or symptom, or the pathophysiology of cystic fibrosis, using clinical, translational, or epidemiologic study approaches. Up to USD $150,000 per year (plus 12 percent indirect costs) for a maximum of three years may be requested for single-center clinical research awards. For multi-center clinical research, the potential award is up to USD $350,000 per year (plus 12 percent for indirect costs) for a maximum of three years. Deadline for Letters of Intent: March 27, 2020; Full application deadline: July 17, 2020.

    • Clinical Pilot and Feasibility Awards. The intent of this award is to enable investigators to collect sufficient preliminary data to determine the best strategies and methods for approaching a major question that ultimately will require assessment through a larger scale research and/or multi-center, collaborative clinical trial. The award is intended to support a project involving human subjects or samples that will develop and test new hypotheses and/or new methods in research areas relevant to cystic fibrosis. Support may be requested for USD $80,000 annually (plus 12 percent for indirect costs) for up to two years. Deadline for Letters of Intent: March 27, 2020; Full application deadline: July 17, 2020.
       

  • Simons Foundation: SFARI Collaboration on Sex Differences in Autism. For this SFARI Collaboration, they welcome proposals that will use an array of modern technologies to examine sex differences in brain function, within and across species, including humans, to identify key differences in gene, cell and circuit function that account for the observed differential sensitivities of the two sexes to ASD. A successful Collaboration must enhance our understanding of the biological bases for sex-specific differences in ASD and set the stage for development of novel interventions. SFARI Collaborations have a maximum budget of up to USD $8,000,000, including 20 percent indirect costs, over an initial period of four years, with a possible three-year extension. Deadline for Letters of Intent: April 21, 2020; Full application deadline: August 21, 2020.
     

  • Prostate Cancer Foundation: 2020 PCF Challenge Awards for Metastatic, Lethal Prostate Cancer.  The PCF is pleased to announce a Request for Team Science Applications for PCF Challenge Awards for investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired. They especially encourage applications on prostate cancer disparity research that will help to define the origins of differential outcome for prostate cancer patients in men of African descent, including those focusing on biology or health care access policy. Applications that include collaborations with Historically Black Colleges and Universities (HBCU) are especially encouraged. They also seek applications conducting research in VA hospitals where research directly affects veterans with advanced prostate cancer. Amount: Up to USD $1 million per team over two years. Deadline for applications: April 17, 2020 at 3pm EDT.
     

  • Wellcome Trust: Epidemic Preparedness - COVID-19 funding call. Wellcome, in partnership with the Department for International Development, invites expressions of interest for its epidemic preparedness - COVID-19 funding call. This aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and increase research and response capacity. Proposals should focus on helping LMICs prepare for and deal with the epidemic. Vaccine development is not eligible. Individuals or teams of up to five members from anywhere in the world, except mainland China, may apply. Lead applicants based in LMICs are particularly encouraged to apply. Amount: Up to GBP £2,000,000 for up to two years. You can apply for this opportunity at any time. Expressions of interest should be submitted as soon as possible. The call may close at any time.
     

  • Sanfilippo Children's Foundation: Project Grants. The Foundation funds research that shows potential to contribute to its vision of finding a cure in time for children battling Sanfilippo today, and those born with it tomorrow. The Foundation is currently calling for expressions of interest for: 1. Translational Research Grants which provide funding for projects with significant potential to move through the translational pipeline towards treatment. This includes pre-clinical and clinical research to develop new treatments. 2. Incubator Grants which focus on small scale projects investigating bright new ideas with the potential to generate results that may attract larger scale funding. Deadline for Expressions of Interest: March 24, 2020; Full application deadline: May 12, 2020.
     

  • Batten Disease Support and Research Association (BDSRA): Annual Funding Cycle. For the current call for LOIs, BDSRA seeks innovative research projects that have the potential to advance therapeutic strategies for all or any of the Neuronal Ceroid Lipofuscinoses. They greatly encourage projects that will pull together multiple funding sources, cross-lab collaborations, and projects that have promise of future NIH, DOD or other government, or industry funding. Amount: Up to USD $40,000 for one year with a potential for renewal. Deadline for Letters of Intent: March 27, 2020.
     

  • DEBRA International: All-Priorities' Research Call Project Grants. The sponsor supports world-class research, worldwide, to increase understanding of the causes and consequences of Epidermolysis Bullosa (EB), and to develop the evidence base for the development of better clinical care, diagnostics, and disease-modifying therapies for those with EB. The overall objective is to find a cure and therapies for people living with Epidermolysis Bullosa. Amount: Up to EUR €90,000 per year for up to three years. Deadline for applications: April 6, 2020.

  • Morton Cure Paralysis Fund (MCPF): Research Grants. The MCPF is committed to developing effective therapies (cures) for paralysis associated with spinal cord injury and other disorders of the central nervous system (CNS). MCPF has particular focus of placing projects in the research pipeline, that is, enabling scientists to develop the proof concept data necessary to apply for larger NIH grants. The development of effective therapies for chronic injury is a high priority for the organization. Basic research will be supported if it has clear potential to accelerate progress at the applied end of the continuum and/or if it reflects innovative research or a 'change of direction. Amount: Up to USD $75,000 based on one-year contracts. Deadline for applications: April 30, 2020.
     

  • Ehlers-Danlos Society: Research Grants - Clinical and Basic Science. Grants aim to support studies likely to require 1-2 years to complete and to cover the costs for researchers and study equipment. Clinical Research Major Grants: All areas of health and social care, and education applicable to our research priorities that have a direct impact on care in the Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD) will be considered. Basic Science Research Major Grants: All areas of the basic sciences applicable to our research priorities that have the potential to be translational in informing better care for people with EDS or HSD will be considered. Amount: Up to USD $150,000. Deadline for applications: May 22, 2020.

 

February 11, 2020
 

  • Rapid research response to the 2019 Novel Coronavirus Outbreak - Urgent funding opportunity. The Government of Canada has announced an Operating Grant funding opportunity: Canadian 2019 Novel Coronavirus (2019-nCoV) Rapid Research Funding Opportunity. This is a Rapid Research Opportunity, so please pay close attention to the tight application deadline, anticipated notice of decision and funding start dates. The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity can be found here. This research response is aligned with the efforts of international partners, including the World Health Organization (WHO) and the Global Research Collaboration for Infectious Disease Preparedness (GLoPID-R). This is a collaboration between CIHR in partnership with NSERC, SSHRC and the International Development Research Centre (IDRC). Application deadline: February 18, 2020; Anticipated Notice of Decision: February 29, 2020.
     
  • Information Session: Addressing EDI and GBA+ in Your NFRF Transformation Letter of Intent. The Division of the Vice-President, Research and Innovation, will hold an information session on addressing equity, diversity, and inclusion (EDI) considerations and gender-based analysis plus (GBA+) in the New Frontiers in Research Fund Transformation competition Letter of Intent. The information session will provide participants with guidance on completing the EDI section of the LOI and will share best practices for team recruitment, training and development, and the creation of an inclusive team environment. In addition, researchers from the University of Toronto will discuss how they have integrated considerations of sex, gender, and diversity into their own research. Presentations will be followed by opportunities for questions and discussion. In addition to the Simcoe Hall session, the event will also be live-streamed to reserved rooms on the UTM and UTSC campuses and will be available to remote participants via Skype For Business, web browser, or phone. Full details and registration information are available here
    DATE: February 20, 2020 from 1:30pm - 3:30pm
    LOCATION: Governing Council Chamber, Simcoe Hall, 27 King's College Circle

     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcements. For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     
  • Cancer Research Society: Scholarships for the Next Generation of Scientists: 2020 Competition. This initiative aims at supporting future generations of Canadian researchers. The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal. Complete details on how to apply can be found here
    Part 1: Postdoctoral Salary Award - 1 year - $50,000. One year postdoctoral salary award for a candidate finishing his/her fellowship. The candidate must have completed at least two years of postdoctoral training at the time he/she accepts the salary award.
    Candidates  should  have  obtained  their doctoral  degree  after  August  31,  2014. This date can be adjusted for maternity or sick leaves
    Part 2: Operating Grant - 2 years - $150,000 ($75,000/year). The operating grant is awarded once the candidate has obtained a faculty position at a recognized Canadian institution. IMPORTANT: Applying for only one part of the award is prohibited.
    Deadline for submissions: April 24, 2020.
     
  • Human Frontiers Science Program (HFSP) Organization: Research Grants. HFSP Research Grants support innovative basic research into fundamental biological problems with emphasis placed on novel and interdisciplinary approaches that involve scientific exchanges across national and disciplinary boundaries. Projects are expected to be at the frontiers of knowledge and therefore entail risk. Participation of scientists from disciplines outside the traditional life sciences such as biophysics, chemistry, computational biology, computer science, engineering, mathematics, nanoscience or physics is recommended. There are two types of Research Grants available: 1. Young Investigator Grants 2. Program Grants. Applied applications, including medical research typically funded by national medical research bodies, will be deemed ineligible. Deadline for compulsory registration: March 19, 2020; Deadline for Letters of Intent: March 30, 2020.
     
  • Fondation Jerome Lejeune: Advanced Grants and Pilot or Exploratory Grants. Spring call for proposals will be dedicated to both Down syndrome and other rare intellectual disabilities from genetic origin such as Fragile X, cri du chat, Rett, Williams-Beuren, Prader-Willi, Angelman, Smith-Magenis and other syndromes, and will not exceed 50% of the total amount of the annual global grant. Autism not linked to above diseases is out of this call for grants. Amounts: Advanced Grants - €40,000 per year for up to two years; Pilot or exploratory grants - €20,000 per year for up to two years. Deadline for proposals: March 6, 2020.
     
  • Brain Tumour Charity.
    • Clinical Biomarkers: This scheme supports the identification, validation, and implementation of clinical biomarkers that bring us closer to an early and accurate diagnosis, and/or inform the management of brain tumours. Studies may make use of the samples and infrastructure brought about by funded clinical trials, to go beyond the primary and secondary endpoints and generate new knowledge around clinical biomarkers. Amount: Up to £100,000 per year for up to five years. This award is open to international researchers but all proposals must demonstrate how they can benefit patients in the UK health system. Deadline for proposals: March 12, 2020.
    • Expanding Theories Awards. This scheme supports pilot studies that explore and develop novel concepts that may eventually lead to significant improvements in clinical outcomes, including quality of life, for people with brain tumours. Amount: up to £60,000 per year, for up to two years. This award is open to international researchers, but applications including a UK collaborator will be looked on favourably. Deadline for proposals: March 12, 2020.
       
  • Davis Phinney Foundation for Parkinson's: Quality of Life Research Grants. The Foundation is actively seeking to fund research projects that address quality of life for people living with Parkinson's. Priority will be given to applications that address the unique needs of historically underrepresented and/or underserved populations, and applications that investigate the benefits and effectiveness of innovations designed to help people with Parkinson's live well. The scientific goals and objectives of the project should be commensurate with the level of support requested and should not overlap with other sources of support. Amount: Up to USD $150,000. Deadline for Letters of Intent: April 1, 2020; Full application deadline: June 19, 2020.
     
  • National Marfan Foundation: Faculty Grant Program. The faculty grant program supports two-year (USD $50,000 per year) grants for basic or clinical research for all disciplines in Marfan syndrome, Ehlers Danlos syndrome, Loeys Dietz syndrome and other related disorders. Special areas of interest include:
    - Basic research, translational studies, and clinical studies in cardiovascular, genetic, orthopedic and ophthalmologic issues utilizing synergistic collaborations
    - Integration of novel theories from non-traditional researchers into established paradigms
    - Novel animal model systems
    - Innovation and the distillation of knowledge into practical new therapies
    Deadline for proposals: April 3, 2020.
     
  • Muscular Dystrophy Association (MDA). Deadline for Letters of Intent: April 1, 2020; Full application deadline: August 1, 2020.
    • Clinical Research Network Grants. MDA supports multiple clinical research networks focused on specific diseases under the MDA umbrella. Each consists of networks of multiple MDA Care Centers with special expertise in clinical research. The Care Centers work together on projects selected by the network, such as natural history studies, endpoint determinations, and other clinical research efforts. The investigators of the networks meet regularly by phone and in person to discuss ongoing and novel programs. Amount: Up to USD $1,000,000 total over one to three years. .
    • Clinical Research Grants. Clinical Research Grants are designed to support observational studies such as natural history, biomarker, and outcome measure studies. Clinical trials of compounds already on the market performed at academic medical centers may also be considered. The maximum budget for these awards is USD $500,000 total over one to three years.
       
  • Action on Hearing Loss: Translational Grant (TRIH Grant)The Translational Grant aims to support and accelerate the translation of research discoveries into potential new treatments to protect and regenerate hearing and /or silence tinnitus. It funds projects at both academic institutions and small/medium enterprises in any country. Amount: Up to £100,000 per year, for up to three years. It supports:
    - research with a strong commercial potential that is likely to attract follow-on funding at the conclusion of the grant
    - studies that will facilitate and enable the progression of promising basic research towards testing in clinical trials.
    Deadline for Expressions of Interest: April 14, 2020: Full application deadline: June 12, 2020.

 

January 31, 2020
 

  • New Frontiers in Research Fund (NFRF) - Transformation. The following NFRF Transformation resources are now available on the University of Toronto Funding Opportunity page (UTORid required):
    • French and English copies of the presentations slides and links to the recorded webinar sessions that TIPS hosted on January 21, 2020 for the NFRF Transformation NOI stage.
    • University of Toronto’s Research Services Office Transformation NOI Tips and Checklist that applicants may use as an additional resource to those available from NFRF.
    • Information on the upcoming University of Toronto information session on Equity, Diversity and Inclusion (EDI) and Gender-Based Analysis Plus (GBA+) in your Letter of Intent:
      Date: February 20, 2020 from 1:30-3:30pm
      Location: Governing Council Chambers, Simcoe Hall, 27 King's College Circle
      This session will be livestreamed to the UTM and UTSC campuses. Further details, including registration information, will be available soon.
       
  • University of Toronto: Connaught Community Partnership Research Program (UTORid required). This program is intended to help create new collaborative research partnerships, or nurture early stage partnerships, between the University and community partners, fostering access to each other’s unique knowledge, expertise and capabilities on issues of shared interest that, over time, may evolve into more established relationships that will attract external funding through, for example, the SSHRC Partnerships Grant program. Proposed projects are expected to be led by a team with representation from academic institutions, community partner organisation(s), and other stakeholder groups, with a research topic driven by needs and questions identified by community partners. Eligible partners include organizations from the not-for-profit or public sector. Projects can request up to $50,000 per year for one to two years, for up to a total of $100,000. Deadline for Notice of Intent (NOI): February 14, 2020; Deadline for full applications: April 1, 2020.
     
  • Early Career Researchers: CIHR Spring 2020 Observer Program. CIHR is pleased to continue to offer an Observer program for Early Career Researchers (ECRs) to participate as an observer in the peer review process of the Project Grant: Spring 2020 competition. This program is designed as an opportunity for Early Career Researchers to observe face-to-face peer review committee meetings and gain valuable insights on the review process. To be eligible to participate in this Observer program, the ECR must be within 60 months of their first independent appointment, as of the application deadline of the Project Grant competition, March 4, 2020. Please note : This program is only open to ECRs working at Canadian institutions. Postdoctoral fellows are not eligible to apply. Deadline to apply: February 13, 2020.
     
  • Webinar: Principles-Based Tri-Agency Guide on Financial Administration. We are pleased to invite the University of Toronto research community to learn more about the new Tri-Agency Guide on Financial Administration (TAGFA) that will be coming into effect on April 1, 2020 by participating in one of the four webinars being offered by the Tri-Agencies in February. The webinar is open to all who hold, manage, or apply for Tri-Agency funding – faculty, business and finance officers, research facilitators and administrators. The new TAGFA will use a principles-based approach to determining eligible expenses on grants awarded by NSERC, SSHRC, or CIHR, retaining some directives on expense eligibility, while deferring more to each institution’s own policies. A team within the Division of the Vice President, Research and Innovation (VPRI) has been working to prepare the University of Toronto for the new TAGFA’s implementation, collaborating closely with other Divisions and learning from the experiences of the twelve institutions in Canada that have been piloting the new guide to date. The team’s work continues and will update the community as we get closer to April 1st with our process. 
    ENGLISH: February 11, 2020 at 2:00 p.m. ET Register; February 12, 2020 at 2:00 p.m. ET Register
    FRENCH:  February 11, 2020 at 11:00 a.m. ET Register; February 12, 2020 at 11:00 a.m. ET Register
     
  • CIHR Team Grants: GACD Primary and Secondary Prevention of Cancer. The sixth call for applications under the Global Alliance for Chronic Diseases (GACD) banner focuses on primary and secondary prevention of cancer. 
    As part of the GACD call, CIHR is launching a funding opportunity in support of projects that focus on implementation research for the primary and/or secondary prevention of cancer in low- and middle-income countries (LMICs) and/or among the Indigenous populations in Canada. Deadline for pre-proposals: February 25, 2020; Deadline for full applications: April 30, 2020.
     
  • Weston Brain Institute: Alzheimer’s & Related Diseases / Parkinson’s & Related Diseases.
    • Rapid Response: Canada 2020. The goal of this program is to provide seed funding for novel, high-risk, high-reward, translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging. Preliminary data is not required for this program. Amount: Up to $300,000 over up to 18 months. 
      Alzheimer’s & Related Diseases: Deadline for LOIs: March 27, 2020. Program Information Webinar: February 14, 2020 at 1:00pm ET.
      Parkinson’s & Related Diseases: Deadline for LOIs: April 30, 2020. Program Information Webinar: March 20, 2020 at 1:00pm ET.
    • Transformation Research: Canada 2020. The goal of this program provide funding for translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging. The program funds transformative, novel, high-risk, high-reward translational research projects. Amount: Up to $1.5M for up to 3 years without need for preliminary data.
      Alzheimer’s & Related Diseases: Deadline for LOIs: March 27, 2020. Program Information Webinar: February 14, 2020 at 1:00pm ET.
      Parkinson’s & Related Diseases: Deadline for LOIs: April 30, 2020. Program Information Webinar: March 20, 2020 at 1:00pm ET.
       
  • Canadian Liver Foundation: Operating Grants. The deadline for submission of operating grant applications is March 31, 2020.  Amount: Up to $60,000 for up to 2 years. Graduate and Summer Studentships are also available. One operating grant may be awarded to a research in Canada for each of these categories whose research is related to:
    • Hepatobiliary research
    • Hepatitis B
    • Liver cancer
       
  • Scleroderma Research Foundation (SRF): Research Grants. The goal of this RFA is to foster the development of research that will advance our understanding of the pathogenesis of scleroderma and to promote the design, development, and pilot testing of hypothesis-driven, innovative therapeutic approaches.rThe SRF also seeks to advance research by promoting collaboration and cross-institutional cooperation among scientists in a variety of disciplines, attracting promising new scientists to scleroderma research, maintaining Scleroderma Centers of Excellence, and bringing new technology and thinking to the field of scleroderma research. Amount: Up to USD $200,000 per year for up to 3 years.
    Deadline for applications for continuing grants: February 10, 2020.
    Deadline application for new grants: February 28, 2020.

     
  • Organization for Autism Research (OAR): Applied Research Competition. Through this competition, OAR intends to promote evidence-based practices delivered from research in the following areas:
    - The analysis, evaluation, or comparison of current models of assessment, intervention, or systems of service delivery, including policy analysis
    - Applied aspects of educational, behavioral, or social/communicative intervention
    - Effective intervention across the lifespan for individuals considered to be severely impacted by autism
    - Adult issues such as continuing education, employment, residential supports, sexuality instruction, quality-of-life determinants, and "later intervention"
    - Issues related to family support, social and community integration, assessment and intervention with challenging behavior, and the use of technology in support of learners with ASD
    Amount: Up to USD $40,000 for 1-2 years. Deadline for preliminary proposals: March 23, 2020; Full applications due August 3, 2020.
     
  • United Mitochondrial Disease Foundation (UMDF): UMDF Research Grants. Awards will be made across a wide spectrum of career stages- from postdoctoral fellows to early stage principal investigators to experienced principal investigators. The Foundation's goal is to both aid in the development of the next generation of scientists dedicated to mitochondrial disease research as well as stimulating new directions for more senior investigators. Projects relating to any form of mitochondrial disease are welcomed in the following research categories: Basic Science, Translation Research; and Clinical Research. Amounts: Accelerators Prize - 50,000 USD for up to 2 years; Early Stage Investigator Prize - 100,000 USD for up to 2 years; and Experienced Principal Investigator Prize - 100,000 USD for up to 2 years. Deadline for proposals: March 2, 2020.
     
  • Jeffrey Modell Foundation: Research Grants - Translational Research Program (Primary Immunodeficiencies). The purposes of this program are:
    - To support innovative and novel investigations in Primary Immunodeficiency, focusing on translational research leading to meaningful clinical application.
    - To advance the growing knowledge of genotype-phenotype correlations and gain a better understanding of the underlying mechanisms of immune function and dysfunction.
    - To support research that will lead to advancement in clinical recognition, diagnostic tools, and innovative therapies that will impact overall health outcomes and improve the quality of life of those affected by Primary Immunodeficiency. 
    Amount: Up to  USD $250,000 over a two-year project period. Funds are not to exceed USD $125,000 per year for each project. Deadline for Letters of Intent: March 16, 2020; Full applications due: July 6, 2020.
     
  • Stiftelsen Promobilia - Promobilia Foundation: Grants for Research and Development Projects. The aim of the Foundation is to promote the development of technical aids so that disabled persons could benefit of a more active life. Our task is to support research and development of technical aids as well as ensure they get into production and reach the needy. The Foundation mainly gives support for development of tools for mobility handicapped but has also supported research about the comprehension of reading and writing difficulties. The Foundation has also supported research around diseases that could lead to severe motion problems. Grants range from 100,000-500,000 SEK (in USD about 50,000). Deadline for applications: March 12, 2020.

January 23, 2020

  • University of Toronto: Institutional Strategic Initiatives - Upcoming Workshops.  Institutional Strategic Initiatives (ISI) at the University of Toronto are large-scale, cross-divisional initiatives that support interdisciplinary teams of our researchers and partners to address grand challenges and pursue bold ideas that require true collaboration and the integration of various disciplinary research approaches. The institutional goal is to improve our capacity to seed, develop, implement and support such initiatives. ISI Workshops provide opportunities for researchers to come together to determine what the foundations could be for these initiatives. Over the next few weeks the following workshops have been scheduled. If you would like to receive more information about a workshop, please contact strat.initiatives@utoronto.ca including your name, academic unit, your research area and which workshop you would like to learn more about. Details on each workshop can be found here. Information on how to develop ISIs, ISI support programs, connecting with upcoming ISI workshops, and templates can be found at http://www.research.utoronto.ca/isi.
    • Beyond Therapy: Community-Engaged Arts Research Creation as a Method for Social Wellness - January 24, 2020 
    • Gender and the Economy - February 4, 2020
    • Healthcare Robotics Interdisciplinary Collaboration - February 12, 2020
    • Plastics - February 19, 2020
    • Materials Acceleration Platforms: AI/Robotics/Computation for accelerated discovery - February 20-21, 2020
    • Mental Health for Youth and Students - TBD
      .
  • 2020 NSERC Collaborative Research and Training Experience (CREATE) - Information Session. NSERC’s CREATE program awards grants of up to $1.65M over 6 years for the development of innovative training programs that enhance collaboration and facilitate the transition of trainees to productive employees in the Canadian workforce. Learn more about this program at our Information Session. Dr. Luis Seco, a former CREATE Committee member will give insights on the program and the application process. Remote Skype details can be found here. The session details are as follows:
    Date: Friday, February 7, 2020 from 2:30pm - 4pm
    Location: McMurrich Building, 12 Queen's Park Cres. West, Room 107
    Please RSVP by February 4th to teresa.trimboli@utoronto.ca.
     
  • Banting-CANSSI Ontario Discovery Award in Data Science. CANSSI Ontario and The Banting Research Foundation are pleased to announce two Banting-CANSSI Ontario Discovery Awards in Data Science. These new investigator awards are a one-year grant of up to $25,000 and are intended to support statistical or computational research related to a health or biomedical problem. Discovery Awards from The Banting Research Foundation support young Canadian researchers who demonstrate excellence and creativity in health and biomedical science. In keeping with the mission of CANSSI Ontario, applicants should be proposing new, innovative statistical or computational methodology, or proposing to implement existing methods in novel ways, to address a health or biomedical research question. Applications will be accepted from new investigators appointed at Ontario Universities. One of the two awards is earmarked for a University of Toronto or affiliated research institute faculty member. Application deadline: February 14, 2020.
     
  • JDRF: Discovery and Development of Strategies for Targeted Drug Delivery to Human Islets for T1D. JDRF aims to catalyze and support innovative studies for the selective delivery of therapeutics (bioactive molecules) to human beta cells, or other major pancreatic cell types, to promote the survival and recover functional beta-cell mass in type 1 diabetes (T1D). Expressions of Interest (EOI) from investigators who would be interested in collaborating with a cross-functional team to help achieve this goal are being solicited. Both validation of existing drug-delivery systems and the discovery of novel drug-delivery systems are of interest. Deadline for Letters of Intent: February 7, 2020 at 5pm ET. Full application deadline: March 20, 2020.
     
  • Ara Parseghian Medical Research Fund (APMRF): Research Grants. The goal of the APMRF is to raise funds that will support research projects to find a treatment for Niemann-Pick Type C (NPC) disease. This funding supports an international research program:
    - To expedite a treatment and cure for NPC disease
    - To promote collaborative research efforts among the world's leading experts in cholesterol metabolism, cell biology, neurobiology, genetics, pharmacology and other areas of science
    - To study similar and further the cause of other neurodegenerative diseases as well as cholesterol storage disorders.
    Research grants will provide support for up to USD $100,000; a few collaborative research grants will provide support for up to USD $250,000. Deadline for Letters of Intent: March 1, 2020; Full application deadline: May 1, 2020.
     
  • Cures Within Reach.
    • Preclinical Repurposing Research to Address Meniere's Disease.  This RFA is seeking preclinical repurposing research projects to address Meniere's disease (MD). We are interested in research testing generic or proprietary drugs, devices, nutraceuticals or diagnostics that could ultimately be repurposed in the clinic to create "new" treatments to 1) reduce the symptoms, progression or incidence for MD; 2) restore function lost to MD; or 3) to reduce or eliminate severe side effects of currently used therapies for MD, thereby improving patient outcomes and quality of life. Amount: Up to USD $50,000. Deadline for proposals: March 9, 2020.
    • Repurposing Research to Improve Clinical Patient Outcomes in Meniere's Disease. This RFA is seeking repurposed treatments to address Meniere's disease (MD). We are interested in generic or proprietary drugs, devices, nutraceuticals or diagnostics that could be repurposed to create "new" treatments to 1) reduce the symptoms, progression or incidence for MD; 2) restore function lost to MD; or 3) to reduce or eliminate severe side effects of currently used therapies for MD, thereby improving patient outcomes and quality of life. Amount: Up to USD $100,000. Deadline for proposals: March 9, 2020.
       
  • International OCD Foundation. 
    • Young Investigator Awards. The intent of these awards is to support promising young investigators who are developing their careers while pursuing creative and impactful research projects on OCD and related disorders across a range of disciplines. Only research projects that investigate topics in the field of OCD and related disorders (OCD, including pediatric OCD; PANS/PANDAS; hoarding disorder; body dysmorphic disorder) will be considered for funding. Amount: Up to USD $50,000. Deadline for proposals: March 2, 2020.
    • Breakthrough Awards. The IOCDF offers the Breakthrough Awards to senior researchers pursuing impactful projects investigating OCD. The Breakthrough Awards are intended to support innovative and potentially-groundbreaking projects – “high-risk, high reward” science that could make a profound impact on the field and accelerate progress toward new and more effective treatments for OCD, and possibly even lead to a cure. Amount: Up to USD $500,000. Deadline for proposals: March 2, 2020.

 

January 17, 2020
 

  • Tri-Agency workshops to improve online grants management systems: January 27, 2020.  CIHR, NSERC, and SSHRC are collaborating on a Tri-Agency initiative to improve the online grants management systems, with an aim to better support the needs of the Canadian research community. For more information on the Tri-Agency Grants Management Solution (TGMS) initiative, please see the TGMS one-pager
    As a part of this initiative, TGMS is engaging users early and often through targeted activities to better understand the research community’s needs. Over the past several months, TGMS has developed journey maps (user process visualizations) through consultation to represent the research community's primary users in the roles of applicants, reviewers, and research administrators. To enhance and deepen the content of the journey maps Tri-Agency is now engaging a larger group of users.

    University of Toronto researchers who have previous experience as applicants and/or reviewers for Tri-Agency granting programs are welcome to register for a consultation workshop. Your participation in this workshop would be indispensable for improving the online grant management experience, both for you and your colleagues. There are two separate workshop sessions scheduled for Monday, January 27th. You are invited to register for one of the following sessions, based on your experience in the roles of an applicant or a reviewer, by clicking on the appropriate registration link:
    APPLICANT WORKSHOP:
    Date/Time: Monday, January 27, 2020 from 9am-12pm
    Location: O.I.S.E., room 8214 (252 Bloor St. W - see campus map)
    Registration Link: https://cris.eve.utoronto.ca/home/events/528
    REVIEWER WORKSHOP:
    Date/Time: Monday, January 27, 2020 from 1pm-4pm
    Location: O.I.S.E., room 5230 (252 Bloor St. W - see campus map)
    Registration Link: https://cris.eve.utoronto.ca/home/events/529
     
  • New Frontiers in Research Fund (NFRF) Transformation WEBINARS. NFRF will be hosting webinars for applicants and research administrators at each stage.  There is a limited number of attendee spots per webinar (approximately 1000) so participants are encouraged to join webinars as a group.  Links to the webinar will be publicly available approximately one hour prior to the start time and are accessible by clicking on “Join Webinar” in the Transformation Competition program page (see “Webinars” section.) Webinars will be recorded and presentations will be available following the session.
    Date/time: Tuesday, January 21, 2020 from 10am - 12pm (ET) French
    Date/time:
    Tuesday, January 21, 2020 from 1pm - 3pm (ET) English
     
  • Connaught Global Challenge Award. $1 million annually will be awarded to support approximately 4 team initiatives of up-to $250K each.  The program aims to heighten UofT’s contribution to important issues facing society through the advancement of knowledge, and the transfer and application of solutions. Global Challenge teams will represent new collaborations involving leading UofT researchers and students from multiple disciplines, along with innovators and thought leaders from other sectors. The program objective is to enhance UofT’s capacity to achieve meaningful outcomes and impact, including but not limited to: major new external funding to further develop solutions to the global challenge, important new partnerships, and/or new research oriented academic programs.
    The competition is open to all areas of scholarship, however applications related to youth and student mental health, climate change and sustainability, research regarding the recommendations of the Truth and Reconciliation Commission, and the President’s Three Priorities are encouraged. The program is open to all full-time professorial staff (tenured or tenure-stream) at the University of Toronto.  Questions regarding eligibility can be directed to the Connaught Secretariat. Deadline for applications: February 3, 2020.
     
  • CIHR Project Grant - Spring 2020: WEBINARS. CIHR will be hosting the following webinars to support participants with the requirements of the funding opportunity “Project Grant – Spring 2020 Competition” and to answer questions on how to apply. Please download and read the presentation available on the registration page prior to the webinar.
    ENGLISH:
    Monday, January 27, 2020 from 1pm - 2pm ET. Register
    Thursday, February 17, 2020 from 3pm - 4pm ET. Register
    FRENCH:
    Monday, January 27, 2020 from 3pm - 4pm ET. Register
    Thursday, February 17, 2020 from 1pm - 2pm ET. Register
     
  • NSERC Collaborative Research & Training Experience (CREATE): INFORMATION SESSION & WEBINARS. The CREATE program supports the training of teams of outstanding students and postdoctoral fellows from Canada and abroad through the development of innovative training programs that encourage collaborative and integrative approaches, address significant scientific challenges associated to Canada's research priorities, and facilitate the transition of new researchers from trainees to productive employees in the Canadian workforce.
    This program involves a two step process.  The first step involves the submission of a Letter of Intent (LOI).  Those selected at the LOI stage will proceed to the second step and submit a full application.  Please note that there is a maximum number of LOI’s that can be submitted.  In the past, the University of Toronto has been able to submit up to 6 LOI’s.  We are waiting confirmation of our quota from NSERC.  If more than 6 LOI’s are submitted, we will conduct an internal peer review to select the top rated projects using the same evaluation criteria as NSERC. This year, the CREATE Program offers two additional opportunities within its current budget envelope. These include an Industrial Stream and an International Collaboration with Germany. Amount: $1,650,000 over 6 years. Further details and additional details about the webinar can be found here (UTOR id required).
    INFORMATION SESSION: An information session will be held by Research Services Office in early February.  Date and time will be confirmed shortly.
    WEBINARS: 
    English: February 6, 2020 from 1pm 3pm ET
    French: February 7, 2020 from 12:30pm - 2:30pm ET
    DEADLINES: If you are interested in submitting an LOI, please advise Jessica Keating (jessica.keating@utoronto.ca) by March 1, 2020 so that we can put together an internal review panel. UofT internal deadline for LOIs: Thursday March 12, 2020 (FIRM); Sponsor deadline for LOIs: May 1, 2020.
     
  • Can-GARD: Clinical and Research Fellowship in Advanced Genomics in Paediatric Rare Disease. The Canadian Gene Cure Advanced Therapies for Rare Disease (Can-GARD) project and the Centre for Genetic Medicine (CGM), with support from the Division of Clinical and Metabolic Genetics at The Hospital for Sick Children (SickKids). As an emerging area in paediatrics, this clinical research genomics fellowship offers clinicians the opportunity to pursue independent research and clinical work in partnership with a wide range of professionals to enhance children’s health and well-being. This one-year training position begins on July 13, 2020. Application deadline has been EXTENDED to February 7, 2020.
     
  • National Multiple Sclerosis Society: Research Grants.  The Society supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation. The Society will add the indirect cost of 10% of the sum requested. Pre-application deadline: February 5, 2020; Full application deadline: February 12, 2020 at 5pm EST.
     
  • Prostate Cancer Foundation: 2020 PCF Young Investigator Awards. These awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used innovatively and flexibly to advance the career and research efforts of the awardee. This for example, includes funding “protected time” or direct costs for laboratory science. This award does not support indirect costs such as institutional overhead. Every PCF Young Investigator is required to be under the direct supervision of 1-3 mentors. Applicants may be working in basic, translational, computational or clinical research and need not be trained specifically in prostate cancer research to be highly competitive. However, successful applicants should be working in an academic research environment capable of supporting transformational prostate cancer research. Applications deadline: March 23, 2020 at 3pm.
     
  • Cancer Research Institute: CRI Irvington Postdoctoral Fellowships Program. This program furthers career development and supports laboratory research for promising young scientists working under the mentorship of leading immunologists. CRI is seeking hypothesis-driven, mechanistic studies in both immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer. Amount: $175,000 over three years. Deadline for applications: April 1, 2020.
     
  • Alport Syndrome Foundation (ASF): Research Program. The principal goal of the Alport Syndrome Foundation, Inc. (ASF) is to find novel treatments to prevent kidney failure and hearing loss in all patients with Alport syndrome. Application Focus: Identification and investigation of target pathways in disease progression; Development of means to improve early-stage, definitive, and predictive diagnosis; and Repurposing of an FDA-approved drug to improve the current standard of care. Early investigators are encouraged to apply. Amount $125,000 over a one-to-two-year timeframe. Deadline for applications: February 7, 2020.
     
  • International Essential Tremor Foundation (IETF): IETF Grant Program. The IETF is requesting proposals for grants addressing the nosology, etiology, pathogenesis, treatment or other topics relevant to essential tremor. The aim of this request is to stimulate inquiry into this poorly understood clinical disorder and to provide support to projects that are innovative and give promise of receiving more substantial support from other sources. Amount: USD 25,000 for one year with the possibility of being renewed for a second year. Deadline for applications: February 28, 2020.
     
  • Batten Disease Support and Research Association (BDSRA): Annual Funding Cycle. BDSRA seeks letters of intent from the Batten and larger lysosomal disease research community for innovative technologies in biomarkers for any of the 14 forms of Batten disease. Development of, or improvement of biomarkers using tissue, blood, urine or imaging are welcome, as are new concepts in development.  Investigators from centers with a history of research in metabolic diseases are strongly encouraged to apply. Amount: USD $40,000; however exceptional applications may be funded at a higher amount if the budget request is justified. Initial grants are awarded for one year with potential of renewal based on progress made during the first year. Deadline for Letters of Intent: March 25, 2020.
     

January 8, 2020
 

  • NSERC - Next phases of Alliance grants. NSERC is pleased to announce that Alliance grants are now open for all Option 1 applications requesting more than $20,000 annually from NSERC.
    Option 2 applications requesting support for up to 90% or 100% of the costs of the project will be accepted in early 2020
    For full details about Alliance grants and how to apply, please visit the University's webage:  (UTORid required). 
    If you have any questions or comments about Alliance grants please contact Alliance@nserc-crsng.gc.ca  and sign up on the Alliance webpage to be added to the mailing list so you can stay up to date on the latest information.
    Please consult the Alliance Latest News page and the updated Frequently Asked Questions for more information on Option 2.
     
  • Crohn's & Colitis Canada: 2020 Innovations in IBD Research. The objective is to fund novel or innovative approaches to IBD research. This grant is intended to stimulate and support research which may not be encompassed within the boundaries of traditional medical research. Research proposals must conform to sound principles of research and may aim to collect pilot data for follow-on application(s). Amount: Up to $50,000 for one year. Application deadline: January 31, 2020 at 5pm.
     
  • 2020 KRESCENT Post-Doctoral Fellowships and New Investigator Award Programs. The application guidelines for these programs are available on the KRESCENT’s website and on the proposalCENTRAL website (https://proposalcentral.altum.com/) Applications in English must be completed via the on-line application system proposalCENTRAL. Please allow extra time to review the system before the application deadline of February 01, 2020. To apply through this site, you will have to set up a profile, and then search for “KRESCENT” or “Kidney” and fill out the KRESCENT application. Please note: the French version of the on-line application system is not available at this time. To apply in French, all forms and guidelines for the 2020 competition can be found on the Krescent website. Questions should be directed to christine.marquis@kidney.ca
     
  • Kidney Foundation of Canada: 2020 Allied Health Kidney Competition - Allied Health Research Grant, Doctoral Fellowship and Scholarship. Applications for the 2020 Allied Health Kidney Research Grant and Doctoral Fellowship Competition must be completed via the on-line application system proposalCENTRAL. Please allow extra time to review the system before the deadline of March 01, 2020. To apply through this site, you will have to set up a profile, and then search for “Kidney” under “Grant Opportunities” and fill out the Allied Health Kidney Research Grant or the Doctoral Fellowship application. To apply to the Allied Health Kidney Scholarship, please visit the Kidney Foundation of Canada’s website.The policies for the 2020 Allied Health Kidney Research Grant and Doctoral Fellowship are also available on The Kidney Foundation of Canada’s Website and on the proposalCENTRAL websitePlease note:  the French version of the on-line application system is not available at this time. To apply in French, all forms and policies for the 2020 competition can be found on the Kidney Foundation of Canada’s website. Questions should be directed to christine.marquis@kidney.ca.
     
  • CIFAR Azrieli Global Scholars Program 2020. This program provides unrestricted research support of $100,000 CAD, leadership training, mentorship, and opportunities for highly-promising early-career researchers in the first five years of a full-time research position to collaborate with colleagues from diverse disciplines. Applicants can be from anywhere in the world, must hold a PhD (or equivalent) and be within the first five years of a full-time academic research position (e.g. Assistant Professor level or equivalent). The Deadline for applications is February 5, 2020. Scholars' research interests must be aligned with the themes of an eligible CIFAR research program. In 2020, the eligible programs are:
  • amFAR: Target Grants. Although applicants may submit research plans exploring any area of basic or preclinical research relevant to providing the foundation for new approaches to an HIV cure, the following represent particular areas of interest: Generate preclinical models that predict clinical trial outcome; Use provirus to elicit destruction of cellular reservoir; and Characterize and manipulate reservoir cell environment. Amount: USD $200,000 (including indirect costs at a maximum rate of 20%) over two years. Deadline for registration: January 17, 2020; Deadline for Letters of Intent: Tuesday January 29, 2020. 
     
  • Savoy Foundation: Research Grants. Research grants are available to individuals working on epilepsy or related subjects. Grants are available to clinicians and/or established scientists. These grants will be for the following purposes: Launch of a project; preliminary studies; Pursuit or completion of a project: temporary support following the interruption or the termination of a grant; Contribution to the funding of a research project of particular interest in the field of epilepsy; Contribution to the funding of a scientific activity. Amount: Up to CAD 25,000. Deadline for applications: January 15, 2020.
     
  • PCS Partners Seeking a Cure: Research Grants. These grants are award to conduct research that addresses an important and novel, basic or clinical research question related to primary sclerosing cholangitis (PSC) and closely associated diseases (such as inflammatory bowel diseases (IBD) and cholangiocarcinoma). This program seeks to encourage investigators to conduct research in promising new areas, with the goal that data generated will lead to federal (NIH) or external international funding. Amount: USD $30,000 per year for two years. Deadline for applications: January 30, 2020.
     
  • FRAXA Research Foundation: FRAXA Fellowships. Each year, FRAXA funds medical research aimed at finding specific treatments and ultimately a cure for Fragile X syndrome. Their goal is to bring practical treatment into current medical practice as quickly as possible; so preference is given to projects that have a clear practical application and the results of which will be shared in a timely fashion. Any scientist is eligible for salary support from these awards (not just postdocs), and a supply budget may be included. Amount: USD $45,000 per year for two years. Deadline for applications: February 1, 2020.
     
  • Kenneth Rainin Foundation: Innovator Awards. The Foundation supports research that is potentially transformative to diagnosing, treating and curing Inflammatory Bowel Disease. The Innovator Awards program provides grants for research projects, which due to their ground-breaking nature, may not be suitable for funding from more traditional sources. Amount: USD up to $200,000, which may include up to 10% for indirect costs. Deadline for LOIs: February 18, 2020; Full proposal due: May 12, 2020.
     
  • Lady Tata Memorial Trust: International Awards for Research in Leukaemia. These awards are restricted to studies of leukaemogenic agents, and the epidemiology, pathogenesis, immunology and genetic basis of leukaemia and related diseases. Amount: Up to £35,000 for one year. On an exceptional basis, an award for a second year can be made. Priority will be given to those intending to move to other centres with a view to establishing scientific collaboration between laboratories. Deadline for applications: March 15, 2020.
     

December 11, 2019
 

  • New Frontiers in Research Fund - Transformation.  The inaugural Transformation competition of the New Frontiers in Research Fund (NFRF) program is now open.
    Transformation stream funding aims to support large-scale, Canadian-led interdisciplinary research projects with the potential to realize real and lasting change (high reward). Projects funded by Transformation Stream Grants:
    1.    tackle a well-defined problem or challenge;
    2.    propose a novel world-leading approach that’s different from current state-of-the-art approaches to the problem or challenge;
    3.    are interdisciplinary bringing different perspectives to the defined problem; and
    4.    have the potential to be transformative – meaning the potential to create a significant and real change or impact, rather than an incremental advance.
    The problem or challenge may be fundamental, leading to a scientific breakthrough, or applied, with a social, economic, environmental or health impact.
    All competition documents are available on the NFRF website.  Applicants will apply using the Convergence Portal
    Value and Duration:  Transformation grants are valued at between $2 million and $4 million annually (inclusive of indirect costs) for up to 6 years.  For this first round, $144 million is available over 6 years, enabling 6-12 projects nationally. Upcoming Webinars and how to apply and other support for applicants can be found here. Sponsor's webpage here.
    NOI - UofT internal MRA deadline: February 13, 2020; NFRF deadline for NOI: February 18, 2020.
     
  • NEW - University of Toronto: Institutional Strategic Initiatives (ISI).  The ISI portfolio is led by the Associate Vice-President and Vice-Provost, Strategic Initiatives (AVPVP SI), with a dual report to the Vice-President & Provost and the Vice-President, Research & Innovation, and Strategic Partnerships, serves as a hub for supporting these interdisciplinary and cross-divisional initiatives. The research groups they are looking to support  “are large-scale, cross-divisional initiatives that support interdisciplinary teams of University of Toronto researchers and partners to come together to address grand challenges and pursue bold ideas. The institutional goal for these initiatives is to improve our capacity to seed, develop, implement and support cross-divisional, interdisciplinary, excellence-driven initiatives.”
    A few notes to take into account;

    1.    To access the to the details and documents in the link above, you will need to use your UTORid.
    2.    There are many points where there is reference to “cross divisional” research. Please keep in mind that in this instance, the “divisions” are faculties (for example; Faculty of Medicine, Faculty of Arts and Science etc).
    3.    Please contact strat.initiatives@utoronto.ca to discuss if your Network meets their criteria to apply.

  • Pre-announcement - CIHR Team Grants: Diabetes Mechanisms and Translational Solutions.  The Team Grants will support multi-disciplinary research to better understand the underlying causes andpathophysiology of diabetes, and develop improved prevention and treatment approaches for diabetes. The total amount available at the LOI stage is $200,000, enough to fund approximately 20 LOIs ($10,000 each). At the full application stage, a total of $20,000,000 is available, enough to fund up to 10 grants. Expected launch date: Early winter.

  • Canadian Cancer Society: CCS Emerging Scholar Award. Through the CCS Emerging Scholar Award program, early career investigators will develop their cancer research programs in Canada and pursue important scientific advances of the highest quality and potential for impact. CCS is committed to supporting all areas and disciplines of cancer research and building capacity across Canada. Applications from the four pillars of health research (ie. biomedical; clinical; health services; and social, cultural, environmental and population health) are encouraged, and geographic and gender diversity will be strongly considered during the evaluation process. Deadline for Letters of Intent: February 5, 2020.
     

  • The Canadian Asthma, Allergy and Immunology Foundation (CAAIF). Deadline for Letters of Intent: January 10, 2020; Full applications (invitation only) due: March 1, 2020.
    • CAAIF Top 10 Challenge Food Allergy Research Grant. This grant is focused on food allergy research and will provide one grant of $25,000 to fund a patient-centered food allergy research grant. Preference will be given to investigators who have not received this award within the past two years.
    • CAAIF/Pediapharm Research Grant in Allergic Diseases. The objective of the CAAIF/Pediapharm Research Grant in Allergic Diseases is to fund a patient-centered food allergy research grant. The maximum value of this award is $25,000.
  • National Multiple Sclerosis Society: Research Grants. The Society supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation. Investigators may request funds for the following categories of expenditure: salaries for professional and nonprofessional personnel, patient costs, permanent equipment, consumable supplies, travel, other expenditures not
    included under the above categories, and indirect costs. Deadline: February 12, 5:00 pm EST (pre-applications due February 5).

  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcements. For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     

  • Alzheimer's Drug Discovery Foundation (ADDF): Deadline for Letters of Intent: January 17, 2020; Full proposal due: February 7, 2020
    • Neuroimaging and CSF Biomarker Development Program. This RFP prioritizes biomarker programs that define a specific use and have potential for commercial and clinical translation, with an emphasis on clinical trials. Amount: Up to USD $600,000 - One year with potential for follow-on funding. Multi-year proposals can be considered.
    • Program to Accelerate Clinical Trials (PACT). The goal of this RFP is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer's disease and related dementias. This includes novel, repurposed, and repositioned drugs as well as natural products. Average Award: Up to USD $3,000,000 based on stage and scope of research. Multi-year. Potential for follow-on funding. 
    • Drug Development Program. This RFP focuses on building preclinical evidence in animal models and on advancing lead molecules to the clinical candidate selection stage. The proposed studies should have a high probability of reaching IND-enabling studies within two years. Average Award: Up to USD $600,000 based on stage and scope of research. One year with potential for follow-on funding. Multi-year proposals can be considered. 
    • Prevention Beyond the Pipeline. The ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.  Amount: USD $50,000-$100,000 for epidemiological analyses based on scope of research; Up to USD $3 million for clinical trials based on stage and scope of research.
       
  • Friedrich's Ataxia Research Alliance (FARA): Keith Michael Andrus Cardiac Research Award. This award was made in honor of its namesake to remember Keith's legacy and to help advanced our understanding and treatment of the cardiomyopathy associated with FA. Proposals for this award should focus on advancing understanding and/or treatment of the cardiac involvement in FA. Amount - Maximum budget: USD $150,000 per year for 1 or 2 years. Deadline for Letters of Intent: January 15, 2020; Full application due: March 1, 2020.
     
  • National Psoriasis Foundation (NPF):
    • Psoriatic Disease Research Fellowships. The program provides support to eligible institutions to develop and enhance the opportunities for physicians training for research careers in academic dermatology, rheumatology, pediatric dermatology, and pediatric rheumatology. Priority consideration will be given to applications that advance psoriatic disease research. Awardees will receive a maximum of USD $50,000 to support their fellowship stipend. Deadline for applications: January 13, 2020.
    • Early Career Research Grants. The NPF is seeking grant applications from graduate students, postdoctoral researchers, and researchers at similar trainee-level positions interested in conducting projects focused on psoriatic disease. The goal of this award is to support scientists at this challenging early career stage and to welcome them into the collaborative community of scientists, clinicians, and patients involved with NPF research. Ultimately, recipients of this award are expected to be in a position to compete for future funding through NPF Discovery or Translational Research Grants and go on to establish successful long-term careers conducting
      psoriatic disease research. Amount: Up to USD $50,000 for one year. Deadline for applications: January 13, 2020.
       

November 26, 2019
 

  • Banting & Best Diabetes Centre (BBDC): Postdoctoral Fellowships 2020/2021. The BBDC will be awarding a number of postdoctoral fellowships to candidates at the post-PhD or post-MD degree stages.  The one-year fellowships normally commencing on July 1, 2020 (and no later than September 1, 2020) are for full-time research training in diabetes.  To be eligible, the candidate's proposed supervisor must be conducting diabetes research and must hold a faculty appointment with the University of Toronto at the level of Assistant, Associate, or Full Professor. The proposed supervisor is also required to be a registered member* of the BBDC at the time of application submission. Candidates must have received a doctoral degree (PhD) after July 2016, or a medical degree (MD) after July 2011 and must be within their first four years of postgraduate research training as of July 1, 2020.
    Deadline for applications: February 4, 2020.
     
  • Commercialization Grants – NSERC Idea to Innovation (I2I).  Four times per year, NSERC accepts applications for its “Idea to Innovation” (I2I) program, for the purpose of accelerating pre-competitive technologies for transfer to a Canadian company. Successful applicants receive awards of up to $125,000 for each phase of their commercialization project, with additional funding available as the project progresses. All projects must be based on inventions disclosed and assigned to the University, and should be managed in conjunction with the Innovations & Partnerships Office (IPO) – the Innovations team in particular can assist with development of the Commercialization Plan, and can also assist in determining the appropriate Phase for your project. For more information please contact Hema Prabhu, Research Funding Administrator at IPO's intake email innovations.partnerships@utoronto.ca or visit NSERC's websiteUofT internal deadline: December 6, 2019; Sponsor deadline: January 6, 2020.
    .
  • The Schwartz Reisman Institute for Technology and Society is currently seeking research ideas from across the University of Toronto community. Under the leadership of Gillian Hadfield, the Schwartz Reisman Chair in Technology and Society, the Institute is currently shaping its research and programming directions. As part of this process, we want to hear your ideas about what problems, ideas, and research projects the Institute could undertake—if you’d like to work with us, we want to hear that too.

    We’re especially interested in ideas that bridge disciplines, bring together technical and non-technical communities, and approach questions about technology and society in new and different ways. Initially, we anticipate a strong focus on artificial intelligence and related technologies. However, this does not mean only, or even primarily, projects that directly engage with applications in AI and technology. We are also seeking ideas for basic research in social sciences and the humanities that can inform core challenges in technology. For example, for AI to align well with human interests and values requires developing our core theory of the nature and dynamics of human systems for determining individual and community interests and values. We are especially interested in hearing from people who are not yet working, and may not plan to work, specifically in AI and related tech fields. 
    We're holding two townhalls specifically focused on exploring research opportunities with faculty that are interested in the Institute, and hope that you'll find one of the one following dates convenient. 
    •    St. George and Scarborough Campuses (Remote participation available) - November 29th from 2:00pm - 3:30pm
    •    Mississauga Campus - December 5th from 1:00pm - 2:30pm
    Please also send any research themes, ideas, or questions to brent.barron@utoronto.ca, and if you'd like to be kept up to date on future information and opportunities from the Schwartz Reisman Institute, please subscribe.

  • Canadian Liver Foundation: CDTRP 2019 Research Innovation Competition. In partnership with the Canadian Donation and Transplantation Research Program (CDTRP), the CLF will be funding a 2019 CDTRP Research Innovation Grant specifically designated for liver donation / transplantation research. Additionally, there are up to 10 other non-organ-specific grants that are available for applications which align with one of the 5 Themes of the CDTRP. The goal of these grants is to advance long-term health outcomes and quality of life for Canadian transplant patients. 
    INFORMATION WEBINARS: December 11, 2019 at 3pm ET or January 16 at 2pm ET. Webinar link: https://cdtrp.zoom.us/j/560945514
    Deadline for applications: February 19, 2020.

  • Pediatric Oncology Group of Ontario (POGO): Seed Funding. Since 2006, POGO has offered Seed Funding Grants (of up to $15,000 each) to facilitate or support feasibility studies, self-contained studies, the development of grant applications, or projects that have the potential to generate data to inform larger studies. The subject matter of the Seed Funding Grants should either fall within one of the above-noted PRU research pillars or demonstrate relevance to the goals and objectives of POGO and the PRU. Registration deadline: December 9, 2019 at 5pm; Deadline for full applications: January 24, 2020.

  • Alliance for Cancer Gene Therapy: 2020 Investigator Award in Cell and Gene Therapy for Cancer. This award is for those conducting cell and gene therapy research in solid tumors with preference given to those researching new approaches to glioblastoma and pancreatic cancers. Candidates for this award must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty. The award provides up to a maximum of $500,000 distributed over 2-3 years, inclusive of a maximum of 10% indirect costs. Abstract deadline: December 3, 2019 at 11am (EST); Invited deadline for full applications: February 14, 2020 at 11 am (EST).

  • Lupus Research Alliance: Funding Opportunities.
    • Lupus Innovation Award.  Provides support for pioneering, high-risk, high-reward approaches to major challenges in lupus research. Amount: up to USD $150,000/year total costs for up to 2 years. Deadline for applications: January 15, 2020.
    • Lupus Mechanisms and Targets Award. Supports highly meritorious research focused on the identification and/or investigation of molecular pathways or targets that will lead to new or improved therapies for patients with lupus. Amount: up to USD $200,000/year total costs for up to three years. Deadline for applications: January 15, 2020.
    • Distinguished Innovator Award: Provides outstanding scientists with substantial support (up to USD $1 million over 4 years) to conduct highly innovative research into the fundamental causes of systemic lupus erythematosus and so provide new directions towards a cure. Deadline for Letters of Intent: March 16, 2020.
  • Leukemia Research Foundation (LRF): Hollis Brownstein New Investigator Research Grants Program. A Letter of Inquiry allows the Leukemia Research Foundation to quickly assess if there is a good match between LRF's goals and the project. If it appears to be a good match, we will request a full proposal. Deadline for Letters of Intent: February 7, 2020; Invited deadline for full applications: March 2, 2020.

  • Simons Foundation Autism Research Initiative (SFARI): Research Award. The goal of the Research Award is to provide support for investigation of key unresolved research questions in autism, particularly those that connect genetic etiologies to brain function and behavior. SFARI welcomes risk and novelty in Research Award proposals, but potential impact on the autism research field will be the most important criterion. Competitive applications will have preliminary data or other relevant groundwork that justifies substantial investment in the proposed topic. Amount: Up to USD $1,300,000, including indirect costs, over a period of up to four years. Application deadline: January 10, 2020.

  • A Foundation Building Strength (AFBS): Stronger 2020 Nemaline Myopathy Research Grant. AFBS is excited to announce a new "Stronger 2020" initiative to fund research grants, advancing our mission to find treatments and solutions for NM. AFBS has and will continue to fund research advancing our understanding of the pathogenesis and potential therapies for NM, as well as devices that support functional and quality of life improvements for NM patients and their caregivers. Each proposal can request a maximum of USD $200,000 for a two-years grant. Most proposals are expected to be in the USD $30,000 - $200,000 range. Deadline for applications: December 20, 2020.

  • Friedreich's Ataxia Research Alliance (FARA): General Research Grant. FARA supports research across the spectrum from basic research through drug development and clinical research programs in FA. FARA grant program priorities: 1. Advancing understanding of neuroscience/ systems; 2. Advancing understanding of cardiac disease in FA; 3. Advance drug discovery; 4. Facilitate the drug development process and translational research; 5. Advance clinical research. Amount: Up to USD $150,000 per year for one or two years. Deadline for Letters of Intent: February 1, 2020; Full application due: April 1, 2020.
     

  • SickKids: Can-GARD: Advanced Therapies for Rare Diseases - 2020 Spring Accelerator Grant Program. The competition is now open for Letter of Intent (LOI) submission (Deadline: Friday, November 30, 2019 at 11:59 PM, EST.)
    Can-GARD aims to fund proposals that would eliminate barriers in the diagnostic or treatment journey for rare disease patients.  It is anticipated that approximately 3 grants will be awarded in this competition. Any topic: Basic research, clinical application, population studies, and machine learning approaches will be considered. The maximum amount per grant is $75,000CDN per year over a one or two year period, depending upon scope and quality.
    Can-GARD has partnered with The Rare Disease Models and Mechanisms (RDMM) Network who will match one grant* which will be made to an RDMM investigator, aiming to take their research on rare disease diagnosis or treatment to the next level. *RDMM/Can-GARD Connect Award – One of the total awards will be supplemented by the RDMM Network.  Maximum amount of this joint award will be $100,000 CDN per year. Full grant proposals: Due April 1, 2020 (11:59pm, EST).